Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab

October 14, 2021

AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science.

Advancing Detection of Unknown Impurities

October 06, 2021

Having intelligent analytical tools can advance the detection of unknown impurities, which is important for ensuring small-molecule ingredient purity.

SGS Completes Expansion of Bioanalytical Testing Laboratory in France

October 04, 2021

The expansion to SGS’s Poitiers facility in France is expected to improve the company’s drug development capabilities.

Determining Shelf Life: Reading the Stability Testing Data

October 02, 2021

Although stability testing programs for small-molecule drugs and biologics are often perceived as similar, stability programs for biologics are far more complex.

Codex DNA Aims to Accelerate Virus Research with Full-Length Synthetic Genome for SARS-CoV-2 Delta Variant

September 30, 2021

In September, Codex DNA released a full-length synthetic genome for the SARS-CoV-2 delta variant, which may accelerate discovery and development of diagnostics and treatments for COVID-19.

LabVantage Solutions Now Offers LabVantage Enterprise SaaS

September 30, 2021

The new LabVantage Enterprise SaaS adds full configurability and custom interfacing capabilities.

Gyros Protein Technologies Announces New Titer Kit

September 30, 2021

Gyros’ new titer kit identifies adeno-associated virus serotype 9 in vector-based cell and gene therapy manufacturing.

USP Publishes General Chapter 1220 of Analytical Procedure Life Cycle

September 29, 2021

USP is publishing the analytics-focused chapter, which considers validation activities, in advance of the official publication.

CuriRx Launches CuriLytics Platform

September 29, 2021

CuriRx’s CuriLytics platform is a mass spectrometry instrument that will support complex biotherapeutics development.

KSL Biomedical Acquires Pulse Scientific, Expanding Laboratory and Assay Capabilities

September 29, 2021

KSL Biomedical announced their expansion into Canada with the acquisition of Pulse Scientific and the incorporation of KSL Biomedical Canada.